ATE292176T1 - Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren - Google Patents

Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren

Info

Publication number
ATE292176T1
ATE292176T1 AT98966368T AT98966368T ATE292176T1 AT E292176 T1 ATE292176 T1 AT E292176T1 AT 98966368 T AT98966368 T AT 98966368T AT 98966368 T AT98966368 T AT 98966368T AT E292176 T1 ATE292176 T1 AT E292176T1
Authority
AT
Austria
Prior art keywords
nucleic acid
acid molecules
weak
phenotype
present
Prior art date
Application number
AT98966368T
Other languages
English (en)
Inventor
Willy A Flegel
Franz F Wagner
Original Assignee
Drk Blutspendedienst Bw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231303&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE292176(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Drk Blutspendedienst Bw filed Critical Drk Blutspendedienst Bw
Application granted granted Critical
Publication of ATE292176T1 publication Critical patent/ATE292176T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98966368T 1998-01-23 1998-12-18 Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren ATE292176T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98101203 1998-01-23
PCT/EP1998/008319 WO1999037763A2 (en) 1998-01-23 1998-12-18 Novel nucleic acid molecules correlated with the rhesus weak d phenotype

Publications (1)

Publication Number Publication Date
ATE292176T1 true ATE292176T1 (de) 2005-04-15

Family

ID=8231303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98966368T ATE292176T1 (de) 1998-01-23 1998-12-18 Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren

Country Status (12)

Country Link
US (1) US7005276B1 (de)
EP (1) EP1047777B1 (de)
JP (1) JP2002500884A (de)
AT (1) ATE292176T1 (de)
AU (1) AU748222B2 (de)
BR (1) BRPI9815090B1 (de)
CA (1) CA2318486C (de)
DE (1) DE69829587T2 (de)
ES (1) ES2241195T3 (de)
IL (1) IL137424A0 (de)
PT (1) PT1047777E (de)
WO (1) WO1999037763A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2342837T3 (es) 1999-11-02 2010-07-15 Drk-Blutspendedienst Baden-Wurttemberg-Hessen Gemeinnutzige Gmbh Estructura molecular de rhd negativo.
AU2001242507A1 (en) * 2000-04-20 2001-11-07 Adnagen Ag Method, diagnostic kit and microarray for determining the rhesus factor
WO2002016396A2 (en) * 2000-08-21 2002-02-28 The New York Blood Center, Inc. Mammalian rh type b glycoprotein ion transporter
US20090186340A1 (en) * 2004-09-22 2009-07-23 University Of The West Of England, Bristol Gene Analysis
EP2118298B1 (de) 2007-02-08 2013-01-09 Sequenom, Inc. Tests auf nukleinsäurebasis für rhd-typisierung
CA3001637A1 (fr) 2015-10-16 2017-04-20 Universite Paris 7-Denis Diderot Procede de production de proteines erythrocytaires
ES2884474T3 (es) 2016-11-23 2021-12-10 Christoph Gassner Determinación del genotipo subyacente al fenotipo S-s-U- del sistema de grupo sanguíneo MNSs
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
US11693016B2 (en) 2018-11-29 2023-07-04 Polymer Technology Systems, Inc. Systems and methods for electrochemical point-of-care detection of hemoglobin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200802B1 (en) * 1993-10-08 2001-03-13 Arch Development Corporation Human peroxisome proliferator activated receptor gamma: compositions and methods

Also Published As

Publication number Publication date
WO1999037763A3 (en) 1999-09-16
WO1999037763A9 (en) 1999-10-28
PT1047777E (pt) 2005-08-31
DE69829587D1 (de) 2005-05-04
CA2318486C (en) 2010-04-20
IL137424A0 (en) 2001-07-24
BRPI9815090B1 (pt) 2016-05-10
AU748222B2 (en) 2002-05-30
JP2002500884A (ja) 2002-01-15
DE69829587T2 (de) 2006-02-09
BR9815090A (pt) 2000-10-17
WO1999037763A2 (en) 1999-07-29
CA2318486A1 (en) 1999-07-29
EP1047777A2 (de) 2000-11-02
EP1047777B1 (de) 2005-03-30
AU2274699A (en) 1999-08-09
ES2241195T3 (es) 2005-10-16
US7005276B1 (en) 2006-02-28

Similar Documents

Publication Publication Date Title
Jantos-Siwy et al. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease
JP5244103B2 (ja) 器官特異的蛋白質およびその使用方法
JP2010500568A5 (de)
EP1965213A3 (de) Microarrays und ihre Verwendungen
CA2131826A1 (en) MN Gene and Protein
CN102695716B (zh) 肝病病情指标糖链标记物
WO2000050900A3 (en) Methods and compositions for diagnosing carcinomas
CN111018974B (zh) 一种抗人心肌肌钙蛋白i的重组抗体
WO2007056680A3 (en) Methods and arrays for identifying human microflora
DE69829587D1 (de) Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren
WO2000026668A3 (en) S100 proteins and autoantibodies as serum markers for cancer
AU3618095A (en) Alk-7 (activin like kinase), a serine threonine kinase receptor
WO2009099561A2 (en) Urinary ca125 peptides as biomarkers of ovarian cancer
AU8503898A (en) Monospecific antibody reactive with fibrinogen and fibrinopeptide
JPWO2006098464A1 (ja) 前立腺がんの診断方法
KR102131860B1 (ko) 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
US10670587B2 (en) Antibody detection method and system
WO2023244680A3 (en) Reagents and methods for cell identification and characterization
CN111018973B (zh) 一种抗人心肌肌钙蛋白i的重组抗体
KR20110027375A (ko) 소세포폐암에 대한 바이오마커 및 이를 이용한 소세포폐암 진단
CN121426957B (zh) 一种抗Nectin-4蛋白单克隆抗体及其相关产品和用途
US20190137498A1 (en) Methods and compositions for detecting cancer
WO2000003687A3 (en) Potassium channel polypeptide and polynucleotide compositions
WO2000070322A3 (en) A-FORM OF CYTOPLASMIC DOMAIN OF nARIA (CRD-NEUREGULIN) AND USES THEREOF
KR102128251B1 (ko) 아르기닌이 메틸화된 drd2에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1047777

Country of ref document: EP

EEFA Change of the company name